UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of report (Date of earliest event reported) August 26, 2004
ALLIED HEALTHCARE PRODUCTS, INC.
------------------------------------------------------------------------------
(Exact Name of Registrant as Specified in Its Charter)
Delaware 0-19266 25-1370721
------------------------------ ------------- -----------------------
(State or Other Jurisdiction (Commission (I.R.S. Employer
of Incorporation) File Number) Identification Number)
1720 Sublette Avenue, St. Louis, Missouri 63110
-----------------------------------------------------------
(Address, Including Zip Code, of Principal Executive Offices)
314-771-2400
-----------------------------------------------------------
(Registrant's Telephone Number, Including Area Code)
-----------------------------------------------------------------
(Former Name or Former Address, if Changed Since Last Report)
--------------------------------------------------------------------------------
Check the appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation of the registrant under the
following provisions:
[ ] Written communications pursuant to Rule 425 under the Securities
Act (17CFR 230.425)
[ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act
(17 CFR 240.14a-12)
[ ] Pre-commencement communications pursuant to Rule 14a-2(b) under
the Exchange Act (17 CFR 240.14d-2(b))
[ ] Pre-commencement communications pursuant to Rule 13e-4(c) under
the Exchange Act (17 CFR 240.13e-4(c))
Section 1 - Registrant's Business and Operations
ITEM 2.02 RESULTS OF OPERATIONS AND FINANCIAL CONDITION.
On August 26, 2004, Allied Healthcare Products, Inc. announced results
for the year and quarter ended June 30, 2004. A copy of the press release making
that announcement is included as Exhibit 99.1 to this report on Form 8-K.
As set forth in the announcement, for the fiscal year ended June 30,
2004, Allied had net income of $1.9 million, or 23 cents per diluted share, on
sales of $59.1 million compared to a loss of $158,000, or negative 2 cents per
share, on sales of $60.9 million for the 2003 fiscal year.
For the fourth quarter ended June 30, 2004, Allied had net income of
$860,000, or 10 cents per diluted share, on sales of $15.3 million compared to a
loss of $106,000, or negative 1 cent per share, on sales of $14.3 million for
the year earlier period.
Section 9 - Financial Statements and Exhibits
(a) Not Applicable
(b) Not Applicable
(c) Exhibits
Exhibit 99.1: Press Release dated August 26, 2004
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934,
the Company has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
Allied Healthcare Products, Inc.
By: /s/ Daniel C. Dunn
-------------------------------
Name: Daniel C. Dunn
Its: Chief Financial Officer
AUGUST 26 , 2004